BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barnetson RA, Tenesa A, Farrington SM, Nicholl ID, Cetnarskyj R, Porteous ME, Campbell H, Dunlop MG. Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N Engl J Med. 2006;354:2751-2763. [PMID: 16807412 DOI: 10.1056/nejmoa053493] [Cited by in Crossref: 313] [Cited by in F6Publishing: 139] [Article Influence: 19.6] [Reference Citation Analysis]
Number Citing Articles
1 Kohonen-Corish M, Weber TK, Lindblom A, Macrae F; Meeting Participants. Report of the combined meeting of the International Society for Gastrointestinal Hereditary Tumours, the Human Variome Project and the National Cancer Institute Colon Cancer Family Registry, Duesseldorf, Germany, 24 June 2009. Fam Cancer 2010;9:705-11. [PMID: 20532640 DOI: 10.1007/s10689-010-9347-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
2 Kastrinos F, Steyerberg EW, Balmaña J, Mercado R, Gallinger S, Haile R, Casey G, Hopper JL, LeMarchand L, Lindor NM, Newcomb PA, Thibodeau SN, Syngal S; Colon Cancer Family Registry. Comparison of the clinical prediction model PREMM(1,2,6) and molecular testing for the systematic identification of Lynch syndrome in colorectal cancer. Gut 2013;62:272-9. [PMID: 22345660 DOI: 10.1136/gutjnl-2011-301265] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
3 Hampel H, de la Chapelle A. How do we approach the goal of identifying everybody with Lynch syndrome? Fam Cancer 2013;12:313-7. [PMID: 23568035 DOI: 10.1007/s10689-013-9611-5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 25] [Article Influence: 4.9] [Reference Citation Analysis]
4 Sehgal R, Sheahan K, O'Connell PR, Hanly AM, Martin ST, Winter DC. Lynch syndrome: an updated review. Genes (Basel) 2014;5:497-507. [PMID: 24978665 DOI: 10.3390/genes5030497] [Cited by in Crossref: 69] [Cited by in F6Publishing: 56] [Article Influence: 8.6] [Reference Citation Analysis]
5 Bartley AN, Luthra R, Saraiya DS, Urbauer DL, Broaddus RR. Identification of cancer patients with Lynch syndrome: clinically significant discordances and problems in tissue-based mismatch repair testing. Cancer Prev Res (Phila). 2012;5:320-327. [PMID: 22086678 DOI: 10.1158/1940-6207.capr-11-0288] [Cited by in Crossref: 77] [Cited by in F6Publishing: 40] [Article Influence: 7.0] [Reference Citation Analysis]
6 Nielsen M, van Steenbergen LN, Jones N, Vogt S, Vasen HF, Morreau H, Aretz S, Sampson JR, Dekkers OM, Janssen-Heijnen ML, Hes FJ. Survival of MUTYH-associated polyposis patients with colorectal cancer and matched control colorectal cancer patients. J Natl Cancer Inst 2010;102:1724-30. [PMID: 21044966 DOI: 10.1093/jnci/djq370] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
7 Tenesa A, Dunlop MG. New insights into the aetiology of colorectal cancer from genome-wide association studies. Nat Rev Genet. 2009;10:353-358. [PMID: 19434079 DOI: 10.1038/nrg 2574] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Matsuno A, Murakami M, Hoya K, Yamada SM, Miyamoto S, Yamada S, Son JH, Nishido H, Ide F, Nagashima H, Sugaya M, Hirohata T, Mizutani A, Okinaga H, Ishii Y, Tahara S, Teramoto A, Osamura RY. Molecular status of pituitary carcinoma and atypical adenoma that contributes the effectiveness of temozolomide. Med Mol Morphol 2014;47:1-7. [PMID: 23955641 DOI: 10.1007/s00795-013-0050-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
9 Baudrin LG, Deleuze JF, How-Kit A. Molecular and Computational Methods for the Detection of Microsatellite Instability in Cancer. Front Oncol 2018;8:621. [PMID: 30631754 DOI: 10.3389/fonc.2018.00621] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 7.3] [Reference Citation Analysis]
10 Cross DS, Rahm AK, Kauffman TL, Webster J, Le AQ, Spencer Feigelson H, Alexander G, Meier P, Onitilo AA, Pawloski PA, Williams AE, Honda S, Daida Y, McCarty CA, Goddard KA; CERGEN study team. Underutilization of Lynch syndrome screening in a multisite study of patients with colorectal cancer. Genet Med 2013;15:933-40. [PMID: 23639899 DOI: 10.1038/gim.2013.43] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
11 Cahill DP, Levine KK, Betensky RA, Codd PJ, Romany CA, Reavie LB, Batchelor TT, Futreal PA, Stratton MR, Curry WT, Iafrate AJ, Louis DN. Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment. Clin Cancer Res 2007;13:2038-45. [PMID: 17404084 DOI: 10.1158/1078-0432.CCR-06-2149] [Cited by in Crossref: 279] [Cited by in F6Publishing: 153] [Article Influence: 18.6] [Reference Citation Analysis]
12 Bruegl AS, Djordjevic B, Urbauer DL, Westin SN, Soliman PT, Lu KH, Luthra R, Broaddus RR. Utility of MLH1 methylation analysis in the clinical evaluation of Lynch Syndrome in women with endometrial cancer. Curr Pharm Des 2014;20:1655-63. [PMID: 23888949 DOI: 10.2174/13816128113199990538] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
13 Samowitz WS, Curtin K, Wolff RK, Tripp SR, Caan BJ, Slattery ML. Microsatellite instability and survival in rectal cancer. Cancer Causes Control. 2009;20:1763-1768. [PMID: 19669908 DOI: 10.1007/s10552-009-9410-3] [Cited by in Crossref: 52] [Cited by in F6Publishing: 57] [Article Influence: 4.0] [Reference Citation Analysis]
14 Limburg PJ, Harmsen WS, Chen HH, Gallinger S, Haile RW, Baron JA, Casey G, Woods MO, Thibodeau SN, Lindor NM. Prevalence of alterations in DNA mismatch repair genes in patients with young-onset colorectal cancer. Clin Gastroenterol Hepatol 2011;9:497-502. [PMID: 21056691 DOI: 10.1016/j.cgh.2010.10.021] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 4.0] [Reference Citation Analysis]
15 Mercado RC, Hampel H, Kastrinos F, Steyerberg E, Balmana J, Stoffel E, Cohn DE, Backes FJ, Hopper JL, Jenkins MA, Lindor NM, Casey G, Haile R, Madhavan S, de la Chapelle A, Syngal S; Colon Cancer Family Registry. Performance of PREMM(1,2,6), MMRpredict, and MMRpro in detecting Lynch syndrome among endometrial cancer cases. Genet Med 2012;14:670-80. [PMID: 22402756 DOI: 10.1038/gim.2012.18] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
16 Overbeek LI, Kets CM, Hebeda KM, Bodmer D, van der Looij E, Willems R, Goossens M, Arts N, Brunner HG, van Krieken JH, Hoogerbrugge N, Ligtenberg MJ. Patients with an unexplained microsatellite instable tumour have a low risk of familial cancer. Br J Cancer 2007;96:1605-12. [PMID: 17453009 DOI: 10.1038/sj.bjc.6603754] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
17 Vafaei S, Roudi R, Madjd Z, Aref AR, Ebrahimi M. Potential theranostics of circulating tumor cells and tumor-derived exosomes application in colorectal cancer. Cancer Cell Int 2020;20:288. [PMID: 32655320 DOI: 10.1186/s12935-020-01389-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
18 Stewart A Phd. Genetic testing strategies in newly diagnosed endometrial cancer patients aimed at reducing morbidity or mortality from lynch syndrome in the index case or her relatives. PLoS Curr 2013;5:ecurrents. [PMID: 24056992 DOI: 10.1371/currents.eogt.b59a6e84f27c536e50db4e46aa26309c] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
19 Roy S, Majumdar AP. Cancer Stem Cells in Colorectal Cancer: Genetic and Epigenetic Changes. J Stem Cell Res Ther 2012;Suppl 7:10342. [PMID: 23565347 DOI: 10.4172/2157-7633.S7-006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
20 Guindalini RS, Win AK, Gulden C, Lindor NM, Newcomb PA, Haile RW, Raymond V, Stoffel E, Hall M, Llor X, Ukaegbu CI, Solomon I, Weitzel J, Kalady M, Blanco A, Terdiman J, Shuttlesworth GA, Lynch PM, Hampel H, Lynch HT, Jenkins MA, Olopade OI, Kupfer SS. Mutation spectrum and risk of colorectal cancer in African American families with Lynch syndrome. Gastroenterology 2015;149:1446-53. [PMID: 26248088 DOI: 10.1053/j.gastro.2015.07.052] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 5.1] [Reference Citation Analysis]
21 Ladabaum U, Wang G, Terdiman J, Blanco A, Kuppermann M, Boland CR, Ford J, Elkin E, Phillips KA. Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis. Ann Intern Med. 2011;155:69-79. [PMID: 21768580 DOI: 10.1059/0003-4819-155-2-201107190-00002] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Lopez NE, Peterson CY. Advances in Biomarkers: Going Beyond the Carcinoembryonic Antigen. Clin Colon Rectal Surg 2016;29:196-204. [PMID: 27582644 DOI: 10.1055/s-0036-1584289] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
23 Crain PR, Zepp JM, Gille S, Jenkins L, Kauffman TL, Shuster E, Goddard KAB, Wilfond BS, Hunter JE. Identifying patients with Lynch syndrome using a universal tumor screening program in an integrated healthcare system. Hered Cancer Clin Pract 2022;20:17. [PMID: 35436948 DOI: 10.1186/s13053-022-00217-1] [Reference Citation Analysis]
24 Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW; American College of Gastroenterology. ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol. 2015;110:223-62; quiz 263. [PMID: 25645574 DOI: 10.1038/ajg.2014.435] [Cited by in Crossref: 735] [Cited by in F6Publishing: 548] [Article Influence: 105.0] [Reference Citation Analysis]
25 Weitzel JN, Blazer KR, MacDonald DJ, Culver JO, Offit K. Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine. CA Cancer J Clin 2011;61:327-59. [PMID: 21858794 DOI: 10.3322/caac.20128] [Cited by in Crossref: 40] [Cited by in F6Publishing: 100] [Article Influence: 3.6] [Reference Citation Analysis]
26 Cho E, Lee JE, Rimm EB, Fuchs CS, Giovannucci EL. Alcohol consumption and the risk of colon cancer by family history of colorectal cancer. Am J Clin Nutr. 2012;95:413-419. [PMID: 22218161 DOI: 10.3945/ajcn.111.022145] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 4.1] [Reference Citation Analysis]
27 Kidambi TD, Blanco A, Myers M, Conrad P, Loranger K, Terdiman JP. Selective Versus Universal Screening for Lynch Syndrome: A Six-Year Clinical Experience. Dig Dis Sci 2015;60:2463-9. [PMID: 24903654 DOI: 10.1007/s10620-014-3234-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
28 Giráldez MD, Balaguer F, Bujanda L, Cuatrecasas M, Muñoz J, Alonso-Espinaco V, Larzabal M, Petit A, Gonzalo V, Ocaña T, Moreira L, Enríquez-Navascués JM, Boland CR, Goel A, Castells A, Castellví-Bel S. MSH6 and MUTYH deficiency is a frequent event in early-onset colorectal cancer. Clin Cancer Res 2010;16:5402-13. [PMID: 20924129 DOI: 10.1158/1078-0432.CCR-10-1491] [Cited by in Crossref: 65] [Cited by in F6Publishing: 32] [Article Influence: 5.4] [Reference Citation Analysis]
29 Backes FJ, Hampel H, Backes KA, Vaccarello L, Lewandowski G, Bell JA, Reid GC, Copeland LJ, Fowler JM, Cohn DE. Are prediction models for Lynch syndrome valid for probands with endometrial cancer? Fam Cancer 2009;8:483-7. [PMID: 19642020 DOI: 10.1007/s10689-009-9273-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
30 Rumilla K, Schowalter KV, Lindor NM, Thomas BC, Mensink KA, Gallinger S, Holter S, Newcomb PA, Potter JD, Jenkins MA, Hopper JL, Long TI, Weisenberger DJ, Haile RW, Casey G, Laird PW, Le Marchand L, Thibodeau SN. Frequency of deletions of EPCAM (TACSTD1) in MSH2-associated Lynch syndrome cases. J Mol Diagn 2011;13:93-9. [PMID: 21227399 DOI: 10.1016/j.jmoldx.2010.11.011] [Cited by in Crossref: 62] [Cited by in F6Publishing: 51] [Article Influence: 5.2] [Reference Citation Analysis]
31 Hunter JE, Arnold KA, Cook JE, Zepp J, Gilmore MJ, Rope AF, Davis JV, Bergen KM, Esterberg E, Muessig KR, Peterson SK, Syngal S, Acheson L, Wiesner G, Reiss J, Goddard KAB. Universal screening for Lynch syndrome among patients with colorectal cancer: patient perspectives on screening and sharing results with at-risk relatives. Fam Cancer 2017;16:377-87. [PMID: 28176204 DOI: 10.1007/s10689-017-9972-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
32 Abdel-Rahman WM. Genomic instability and carcinogenesis: an update. Curr Genomics 2008;9:535-41. [PMID: 19516960 DOI: 10.2174/138920208786847926] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
33 Tenesa A, Dunlop MG. New insights into the aetiology of colorectal cancer from genome-wide association studies. Nat Rev Genet. 2009;10:353-358. [PMID: 19434079 DOI: 10.1038/nrg2574] [Cited by in Crossref: 282] [Cited by in F6Publishing: 272] [Article Influence: 23.5] [Reference Citation Analysis]
34 Yang M, Li D, Jiang W, Zhu L, Ju H, Sun Y, Shan Y, Yang C, Dong J, Wang L, Wu B, Qiu M, Yin X, Wang X, Xiong B, Yan W, Liu T, Liu C, Mao X, Ding K, Zhang S, Zheng S, Xu D, Ding P, Yuan Y. Development and external validation of a novel nomogram for screening Chinese Lynch syndrome: based on a multicenter, population study. Ther Adv Med Oncol 2021;13:17588359211023290. [PMID: 34178123 DOI: 10.1177/17588359211023290] [Reference Citation Analysis]
35 Mitchell RJ, Ferguson RK, Macdonald A, Dunlop MG, Campbell H, Porteous ME. Cascade genetic testing for mismatch repair gene mutations. Fam Cancer 2008;7:293-301. [PMID: 18389387 DOI: 10.1007/s10689-008-9192-x] [Reference Citation Analysis]
36 Ladabaum U, Wang G, Terdiman J, Blanco A, Kuppermann M, Boland CR, Ford J, Elkin E, Phillips KA. Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis. Ann Intern Med 2011;155:69-79. [PMID: 21768580 DOI: 10.7326/0003-4819-155-2-201107190-00002] [Cited by in Crossref: 236] [Cited by in F6Publishing: 207] [Article Influence: 21.5] [Reference Citation Analysis]
37 Li D, Hu F, Wang F, Cui B, Dong X, Zhang W, Lin C, Li X, Wang D, Zhao Y. Prevalence of pathological germline mutations of hMLH1 and hMSH2 genes in colorectal cancer. PLoS One 2013;8:e51240. [PMID: 23526924 DOI: 10.1371/journal.pone.0051240] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
38 Roelands J, Hendrickx W, Zoppoli G, Mall R, Saad M, Halliwill K, Curigliano G, Rinchai D, Decock J, Delogu LG, Turan T, Samayoa J, Chouchane L, Ballestrero A, Wang E, Finetti P, Bertucci F, Miller LD, Galon J, Marincola FM, Kuppen PJK, Ceccarelli M, Bedognetti D. Oncogenic states dictate the prognostic and predictive connotations of intratumoral immune response. J Immunother Cancer 2020;8:e000617. [PMID: 32376723 DOI: 10.1136/jitc-2020-000617] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 19.0] [Reference Citation Analysis]
39 Srdjan M, Jadranka A, Ivan D, Branimir Z, Daniela B, Petar S, Velimir M, Zoran K. Microsatellite instability & survival in patients with stage II/III colorectal carcinoma. Indian J Med Res 2016;143:S104-11. [PMID: 27748284 DOI: 10.4103/0971-5916.191801] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
40 Lobello C, Bikos V, Janikova A, Pospisilova S. The Role of Oncogenic Tyrosine Kinase NPM-ALK in Genomic Instability. Cancers (Basel) 2018;10:E64. [PMID: 29510549 DOI: 10.3390/cancers10030064] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
41 Kastrinos F, Steyerberg EW, Mercado R, Balmaña J, Holter S, Gallinger S, Siegmund KD, Church JM, Jenkins MA, Lindor NM, Thibodeau SN, Burbidge LA, Wenstrup RJ, Syngal S. The PREMM(1,2,6) model predicts risk of MLH1, MSH2, and MSH6 germline mutations based on cancer history. Gastroenterology 2011;140:73-81. [PMID: 20727894 DOI: 10.1053/j.gastro.2010.08.021] [Cited by in Crossref: 123] [Cited by in F6Publishing: 112] [Article Influence: 10.3] [Reference Citation Analysis]
42 Hodan R, Kingham K, Cotter K, Folkins AK, Kurian AW, Ford JM, Longacre T. Prevalence of Lynch syndrome in women with mismatch repair-deficient ovarian cancer. Cancer Med 2021;10:1012-7. [PMID: 33369189 DOI: 10.1002/cam4.3688] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
43 Barrow E, Hill J, Evans DG. Cancer risk in Lynch Syndrome. Fam Cancer. 2013;12:229-240. [PMID: 23604856 DOI: 10.1007/s10689-013-9615-1] [Cited by in Crossref: 114] [Cited by in F6Publishing: 99] [Article Influence: 14.3] [Reference Citation Analysis]
44 Zaanan A, Meunier K, Sangar F, Fléjou JF, Praz F. Microsatellite instability in colorectal cancer: from molecular oncogenic mechanisms to clinical implications. Cell Oncol (Dordr) 2011;34:155-76. [PMID: 21484480 DOI: 10.1007/s13402-011-0024-x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 3.4] [Reference Citation Analysis]
45 Jensen SA, Vainer B, Kruhøffer M, Sørensen JB. Microsatellite instability in colorectal cancer and association with thymidylate synthase and dihydropyrimidine dehydrogenase expression. BMC Cancer. 2009;9:25. [PMID: 19154585 DOI: 10.1186/1471-2407-9-25] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 1.7] [Reference Citation Analysis]
46 Iyama T, Wilson DM 3rd. DNA repair mechanisms in dividing and non-dividing cells. DNA Repair (Amst) 2013;12:620-36. [PMID: 23684800 DOI: 10.1016/j.dnarep.2013.04.015] [Cited by in Crossref: 394] [Cited by in F6Publishing: 350] [Article Influence: 43.8] [Reference Citation Analysis]
47 Theodoratou E, Farrington SM, Timofeeva M, Din FV, Svinti V, Tenesa A, Liu T, Lindblom A, Gallinger S, Campbell H, Dunlop MG. Genome-wide scan of the effect of common nsSNPs on colorectal cancer survival outcome. Br J Cancer 2018;119:988-93. [PMID: 30135471 DOI: 10.1038/s41416-018-0117-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
48 Holter S, Hall MJ, Hampel H, Jasperson K, Kupfer SS, Larsen Haidle J, Mork ME, Palaniapppan S, Senter L, Stoffel EM, Weissman SM, Yurgelun MB. Risk assessment and genetic counseling for Lynch syndrome - Practice resource of the National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer. J Genet Couns 2022. [PMID: 35001450 DOI: 10.1002/jgc4.1546] [Reference Citation Analysis]
49 Castells A, Balaguer F, Castellví-Bel S, Gonzalo V, Ocaña T. Identification of Lynch syndrome: How should we proceed in the 21st century? World J Gastroenterol 2007; 13(33): 4413-4416 [PMID: 17724794 DOI: 10.3748/wjg.v13.i33.4413] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
50 Rashid MU, Naeemi H, Muhammad N, Loya A, Lubiński J, Jakubowska A, Yusuf MA. Prevalence and spectrum of MLH1, MSH2, and MSH6 pathogenic germline variants in Pakistani colorectal cancer patients. Hered Cancer Clin Pract 2019;17:29. [PMID: 31660093 DOI: 10.1186/s13053-019-0128-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
51 Hu F, Li D, Wang Y, Yao X, Zhang W, Liang J, Lin C, Ren J, Zhu L, Wu Z, Li S, Li Y, Zhao X, Cui B, Dong X, Tian S, Zhao Y. Novel DNA variants and mutation frequencies of hMLH1 and hMSH2 genes in colorectal cancer in the Northeast China population. PLoS One 2013;8:e60233. [PMID: 23573243 DOI: 10.1371/journal.pone.0060233] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
52 Pérez Segura P, Guillén Ponce C, Ramón y Cajal T, Serrano Blanch R, Aranda E. TTD consensus document on the diagnosis and management of hereditary colorectal cancer. Clin Transl Oncol 2010;12:356-66. [PMID: 20466620 DOI: 10.1007/s12094-010-0517-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
53 Campos S, Amaro P, Cunha I, Fraga J, Cipriano MA, Tomé L. Uncertainties in the Management of a Lynch Syndrome Patient: A Case Report. GE Port J Gastroenterol 2017;24:241-6. [PMID: 29255760 DOI: 10.1159/000461590] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
54 Kastrinos F, Allen JI, Stockwell DH, Stoffel EM, Cook EF, Mutinga ML, Balmaña J, Syngal S. Development and validation of a colon cancer risk assessment tool for patients undergoing colonoscopy. Am J Gastroenterol 2009;104:1508-18. [PMID: 19491864 DOI: 10.1038/ajg.2009.135] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 3.8] [Reference Citation Analysis]
55 Takeda T, Tsuji K, Banno K, Yanokura M, Kobayashi Y, Tominaga E, Aoki D. Screening for Lynch syndrome using risk assessment criteria in patients with ovarian cancer. J Gynecol Oncol 2018;29:e29. [PMID: 29400022 DOI: 10.3802/jgo.2018.29.e29] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
56 Kamiza AB, Hsieh LL, Tang R, Chien HT, Lai CH, Chiu LL, Lo TP, Hung KY, You JF, Wang WC, Hsiung CA, Yeh CC. Polymorphisms of DNA repair genes are associated with colorectal cancer in patients with Lynch syndrome. Mol Genet Genomic Med 2018. [PMID: 29664240 DOI: 10.1002/mgg3.402] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
57 Woods T, Jennings NB, Fernandez HT, Onaca N, Carlile BK, Levy MF, Gould DL, Ruiz R. Renal Autotransplantation in Lynch Syndrome: A Viable Option in a Patient With Contralateral Metachronous Ureteral Cancer. Am J Transplant 2015;15:2507-10. [PMID: 25847116 DOI: 10.1111/ajt.13279] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
58 Overbeek LI, Hermens RP, van Krieken JH, Adang EM, Casparie M, Nagengast FM, Ligtenberg MJ, Hoogerbrugge N; MIPA study group. Electronic reminders for pathologists promote recognition of patients at risk for Lynch syndrome: cluster-randomised controlled trial. Virchows Arch 2010;456:653-9. [PMID: 20379742 DOI: 10.1007/s00428-010-0907-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
59 Gemmell AP, Mauer CB, Reys BD, Pirzadeh-Miller S, Ross TS. Family still matters: Counseling patients with complex family histories of colon and endometrial cancers. Mol Genet Genomic Med 2019;7:e886. [PMID: 31347304 DOI: 10.1002/mgg3.886] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
60 Khan O, Blanco A, Conrad P, Gulden C, Moss TZ, Olopade OI, Kupfer SS, Terdiman J. Performance of Lynch syndrome predictive models in a multi-center US referral population. Am J Gastroenterol 2011;106:1822-7; quiz 1828. [PMID: 21747416 DOI: 10.1038/ajg.2011.200] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
61 Gong R, He Y, Liu XY, Wang HY, Sun LY, Yang XH, Li B, Cao XK, Ye ZL, Kong LH, Zhang DD, Li YH, Xu RH, Shao JY. Mutation spectrum of germline cancer susceptibility genes among unselected Chinese colorectal cancer patients. Cancer Manag Res 2019;11:3721-39. [PMID: 31118792 DOI: 10.2147/CMAR.S193985] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
62 Coelho H, Jones-Hughes T, Snowsill T, Briscoe S, Huxley N, Frayling IM, Hyde C. A systematic review of test accuracy studies evaluating molecular micro-satellite instability testing for the detection of individuals with lynch syndrome. BMC Cancer 2017;17:836. [PMID: 29221446 DOI: 10.1186/s12885-017-3820-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
63 Tenesa A, Farrington SM, Prendergast JG, Porteous ME, Walker M, Haq N, Barnetson RA, Theodoratou E, Cetnarskyj R, Cartwright N. Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nat Genet. 2008;40:631-637. [PMID: 18372901 DOI: 10.1038/ng.133] [Cited by in Crossref: 439] [Cited by in F6Publishing: 409] [Article Influence: 31.4] [Reference Citation Analysis]
64 Fang Z, Xiong Y, Zhang C, Li J, Liu L, Li M, Zhang W, Wan J. Coexistence of copy number increases of ZNF217 and CYP24A1 in colorectal cancers in a Chinese population. Oncol Lett 2010;1:925-30. [PMID: 22966406 DOI: 10.3892/ol_00000163] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
65 Baglietto L, Lindor NM, Dowty JG, White DM, Wagner A, Gomez Garcia EB, Vriends AH, Cartwright NR, Barnetson RA, Farrington SM. Risks of Lynch syndrome cancers for MSH6 mutation carriers. J Natl Cancer Inst. 2010;102:193-201. [PMID: 20028993 DOI: 10.1093/jnci/djp473] [Cited by in Crossref: 244] [Cited by in F6Publishing: 208] [Article Influence: 18.8] [Reference Citation Analysis]
66 Muller C, Matthews L, Kupfer SS, Weiss JM. Effective Identification of Lynch Syndrome in Gastroenterology Practice. Curr Treat Options Gastroenterol 2019;17:666-80. [PMID: 31677041 DOI: 10.1007/s11938-019-00261-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
67 Echle A, Grabsch HI, Quirke P, van den Brandt PA, West NP, Hutchins GGA, Heij LR, Tan X, Richman SD, Krause J, Alwers E, Jenniskens J, Offermans K, Gray R, Brenner H, Chang-Claude J, Trautwein C, Pearson AT, Boor P, Luedde T, Gaisa NT, Hoffmeister M, Kather JN. Clinical-Grade Detection of Microsatellite Instability in Colorectal Tumors by Deep Learning. Gastroenterology 2020; 159: 1406-1416. e11. [PMID: 32562722 DOI: 10.1053/j.gastro.2020.06.021] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 19.5] [Reference Citation Analysis]
68 Pearlman R, Frankel WL, Swanson B, Zhao W, Yilmaz A, Miller K, Bacher J, Bigley C, Nelsen L, Goodfellow PJ, Goldberg RM, Paskett E, Shields PG, Freudenheim JL, Stanich PP, Lattimer I, Arnold M, Liyanarachchi S, Kalady M, Heald B, Greenwood C, Paquette I, Prues M, Draper DJ, Lindeman C, Kuebler JP, Reynolds K, Brell JM, Shaper AA, Mahesh S, Buie N, Weeman K, Shine K, Haut M, Edwards J, Bastola S, Wickham K, Khanduja KS, Zacks R, Pritchard CC, Shirts BH, Jacobson A, Allen B, de la Chapelle A, Hampel H;  Ohio Colorectal Cancer Prevention Initiative Study Group. Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer. JAMA Oncol. 2017;3:464-471. [PMID: 27978560 DOI: 10.1001/jamaoncol.2016.5194] [Cited by in Crossref: 271] [Cited by in F6Publishing: 234] [Article Influence: 54.2] [Reference Citation Analysis]
69 Pino MS, Chung DC. Application of molecular diagnostics for the detection of Lynch syndrome. Expert Rev Mol Diagn. 2010;10:651-665. [PMID: 20629513 DOI: 10.1586/erm.10.45] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
70 Kastrinos F, Ojha RP, Leenen C, Alvero C, Mercado RC, Balmaña J, Valenzuela I, Balaguer F, Green R, Lindor NM, Thibodeau SN, Newcomb P, Win AK, Jenkins M, Buchanan DD, Bertario L, Sala P, Hampel H, Syngal S, Steyerberg EW; Lynch Syndrome prediction model validation study group. Comparison of Prediction Models for Lynch Syndrome Among Individuals With Colorectal Cancer. J Natl Cancer Inst 2016;108:djv308. [PMID: 26582061 DOI: 10.1093/jnci/djv308] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
71 Kacew AJ, Strohbehn GW, Saulsberry L, Laiteerapong N, Cipriani NA, Kather JN, Pearson AT. Artificial Intelligence Can Cut Costs While Maintaining Accuracy in Colorectal Cancer Genotyping. Front Oncol 2021;11:630953. [PMID: 34168975 DOI: 10.3389/fonc.2021.630953] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology. 2010;138:2073-2087. [PMID: 20420947 DOI: 10.1053/j.gastro.2009.12.064] [Cited by in Crossref: 1009] [Cited by in F6Publishing: 921] [Article Influence: 84.1] [Reference Citation Analysis]
73 Goverde A, Spaander MCW, Nieboer D, van den Ouweland AMW, Dinjens WNM, Dubbink HJ, Tops CJ, Ten Broeke SW, Bruno MJ, Hofstra RMW, Steyerberg EW, Wagner A. Evaluation of current prediction models for Lynch syndrome: updating the PREMM5 model to identify PMS2 mutation carriers. Fam Cancer 2018;17:361-70. [PMID: 28933000 DOI: 10.1007/s10689-017-0039-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
74 Vasen HF, Möslein G, Alonso A, Bernstein I, Bertario L, Blanco I, Burn J, Capella G, Engel C, Frayling I. Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet. 2007;44:353-362. [PMID: 17327285 DOI: 10.1136/jmg.2007.048991] [Cited by in Crossref: 373] [Cited by in F6Publishing: 295] [Article Influence: 24.9] [Reference Citation Analysis]
75 Zhu F, Pan D, Zhang H, Ye Q, Xu P, Pan J. Single-center study of Lynch syndrome screening in colorectal polyps. Hered Cancer Clin Pract 2019;17:9. [PMID: 30918532 DOI: 10.1186/s13053-019-0108-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
76 Gomy I, Estevez Diz Mdel P. Hereditary cancer risk assessment: essential tools for a better approach. Hered Cancer Clin Pract 2013;11:16. [PMID: 24165150 DOI: 10.1186/1897-4287-11-16] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
77 Overbeek LI, Hoogerbrugge N, van Krieken JH, Nagengast FM, Ruers TJ, Ligtenberg MJ, Hermens RP; MIPA Study Group. Most patients with colorectal tumors at young age do not visit a cancer genetics clinic. Dis Colon Rectum 2008;51:1249-54. [PMID: 18536968 DOI: 10.1007/s10350-008-9345-x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
78 Mishra N, Hall J. Identification of patients at risk for hereditary colorectal cancer. Clin Colon Rectal Surg. 2012;25:67-82. [PMID: 23730221 DOI: 10.1055/s-0032-1313777] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
79 Kóder G, Olasz J, Tanyi JL, George E, Tóth L, Antal-Szalmás P, Nagy B Jr, Bubán T, András C, Urbancsek H, Laczik M, Csuka O, Damjanovich L, Tanyi M. Identification of Novel Pathogenic Sequence Variants of the Mismatch Repair Genes During Screening for Lynch Syndrome in a Single Centre of Eastern Hungary. J Gastrointest Cancer 2020;51:1007-15. [PMID: 31939059 DOI: 10.1007/s12029-020-00359-2] [Reference Citation Analysis]
80 Solomon I, Harrington E, Hooker G, Erby L, Axilbund J, Hampel H, Semotiuk K, Blanco A, Klein WMP, Giardiello F, Leonard L. Lynch Syndrome Limbo: Patient Understanding of Variants of Uncertain Significance. J Genet Couns 2017;26:866-77. [PMID: 28127677 DOI: 10.1007/s10897-017-0066-y] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
81 Giglia MD, Chu DI. Familial Colorectal Cancer: Understanding the Alphabet Soup. Clin Colon Rectal Surg 2016;29:185-95. [PMID: 27582643 DOI: 10.1055/s-0036-1584290] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
82 Gryfe R. Inherited colorectal cancer syndromes. Clin Colon Rectal Surg 2009;22:198-208. [PMID: 21037810 DOI: 10.1055/s-0029-1242459] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
83 Penson RT. Cycles within cycles. Menopause 2008;15:412-3. [PMID: 18391835 DOI: 10.1097/gme.0b013e31816f70bd] [Reference Citation Analysis]
84 Liu Y, GuLiBaHa M, Yue YB, Li MW, Cao SB, Yan M. An isolated childhood myeloid sarcoma with germline MSH6 mutation-a case report. Transl Pediatr 2021;10:2136-43. [PMID: 34584885 DOI: 10.21037/tp-21-326] [Reference Citation Analysis]
85 Leclerc J, Vermaut C, Buisine MP. Diagnosis of Lynch Syndrome and Strategies to Distinguish Lynch-Related Tumors from Sporadic MSI/dMMR Tumors. Cancers (Basel) 2021;13:467. [PMID: 33530449 DOI: 10.3390/cancers13030467] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
86 Dinh TA, Rosner BI, Atwood JC, Boland CR, Syngal S, Vasen HF, Gruber SB, Burt RW. Health benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general population. Cancer Prev Res (Phila). 2011;4:9-22. [PMID: 21088223 DOI: 10.1158/1940-6207.CAPR-10-0262] [Cited by in Crossref: 123] [Cited by in F6Publishing: 73] [Article Influence: 10.3] [Reference Citation Analysis]
87 Cohen SA. Current Lynch syndrome tumor screening practices: a survey of genetic counselors. J Genet Couns 2014;23:38-47. [PMID: 23674164 DOI: 10.1007/s10897-013-9603-5] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 4.1] [Reference Citation Analysis]
88 Shia J. Immunohistochemistry vs microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry. J Mol Diagn. 2008;10:293-300. [PMID: 18556767 DOI: 10.2353/jmoldx.2008.080031] [Cited by in Crossref: 372] [Cited by in F6Publishing: 343] [Article Influence: 26.6] [Reference Citation Analysis]
89 Palomaki GE, McClain MR, Melillo S, Hampel HL, Thibodeau SN. EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome. Genet Med 2009;11:42-65. [PMID: 19125127 DOI: 10.1097/GIM.0b013e31818fa2db] [Cited by in Crossref: 326] [Cited by in F6Publishing: 168] [Article Influence: 25.1] [Reference Citation Analysis]
90 Stigliano V, Assisi D, Cosimelli M, Palmirotta R, Giannarelli D, Mottolese M, Mete LS, Mancini R, Casale V. Survival of hereditary non-polyposis colorectal cancer patients compared with sporadic colorectal cancer patients. J Exp Clin Cancer Res 2008;27:39. [PMID: 18803843 DOI: 10.1186/1756-9966-27-39] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
91 Weissman SM, Bellcross C, Bittner CC, Freivogel ME, Haidle JL, Kaurah P, Leininger A, Palaniappan S, Steenblock K, Vu TM, Daniels MS. Genetic counseling considerations in the evaluation of families for Lynch syndrome--a review. J Genet Couns 2011;20:5-19. [PMID: 20931355 DOI: 10.1007/s10897-010-9325-x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
92 Baltić V. Application of Genomics in Clinical Oncology. Journal of Medical Biochemistry 2007;26:79-93. [DOI: 10.2478/v10011-007-0011-y] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
93 Seppälä TT, Böhm JP, Friman M, Lahtinen L, Väyrynen VM, Liipo TK, Ristimäki AP, Kairaluoma MV, Kellokumpu IH, Kuopio TH, Mecklin JP. Combination of microsatellite instability and BRAF mutation status for subtyping colorectal cancer. Br J Cancer 2015;112:1966-75. [PMID: 25973534 DOI: 10.1038/bjc.2015.160] [Cited by in Crossref: 71] [Cited by in F6Publishing: 70] [Article Influence: 10.1] [Reference Citation Analysis]
94 Kastrinos F, Stoffel EM. History, genetics, and strategies for cancer prevention in Lynch syndrome. Clin Gastroenterol Hepatol. 2014;12:715-727; quiz e41-3. [PMID: 23891921 DOI: 10.1016/j.cgh.2013.06.031] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 5.0] [Reference Citation Analysis]
95 Kastrinos F, Uno H, Ukaegbu C, Alvero C, McFarland A, Yurgelun MB, Kulke MH, Schrag D, Meyerhardt JA, Fuchs CS, Mayer RJ, Ng K, Steyerberg EW, Syngal S. Development and Validation of the PREMM5 Model for Comprehensive Risk Assessment of Lynch Syndrome. J Clin Oncol 2017;35:2165-72. [PMID: 28489507 DOI: 10.1200/JCO.2016.69.6120] [Cited by in Crossref: 71] [Cited by in F6Publishing: 39] [Article Influence: 14.2] [Reference Citation Analysis]
96 Ishida H, Yamaguchi T, Tanakaya K, Akagi K, Inoue Y, Kumamoto K, Shimodaira H, Sekine S, Tanaka T, Chino A, Tomita N, Nakajima T, Hasegawa H, Hinoi T, Hirasawa A, Miyakura Y, Murakami Y, Muro K, Ajioka Y, Hashiguchi Y, Ito Y, Saito Y, Hamaguchi T, Ishiguro M, Ishihara S, Kanemitsu Y, Kawano H, Kinugasa Y, Kokudo N, Murofushi K, Nakajima T, Oka S, Sakai Y, Tsuji A, Uehara K, Ueno H, Yamazaki K, Yoshida M, Yoshino T, Boku N, Fujimori T, Itabashi M, Koinuma N, Morita T, Nishimura G, Sakata Y, Shimada Y, Takahashi K, Tanaka S, Tsuruta O, Yamaguchi T, Sugihara K, Watanabe T; Japanese Society for Cancer of the Colon and Rectum. Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2016 for the Clinical Practice of Hereditary Colorectal Cancer (Translated Version). J Anus Rectum Colon 2018;2:S1-S51. [PMID: 31773066 DOI: 10.23922/jarc.2017-028] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
97 Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Clendenning M, Sotamaa K, Prior T, Westman JA, Panescu J, Fix D, Lockman J, LaJeunesse J, Comeras I, de la Chapelle A. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol 2008;26:5783-8. [PMID: 18809606 DOI: 10.1200/JCO.2008.17.5950] [Cited by in Crossref: 540] [Cited by in F6Publishing: 280] [Article Influence: 38.6] [Reference Citation Analysis]
98 Edwards RA, Witherspoon M, Wang K, Afrasiabi K, Pham T, Birnbaumer L, Lipkin SM. Epigenetic repression of DNA mismatch repair by inflammation and hypoxia in inflammatory bowel disease-associated colorectal cancer. Cancer Res. 2009;69:6423-6429. [PMID: 19638594 DOI: 10.1158/0008-5472.can-09-1285] [Cited by in Crossref: 52] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
99 Jenkins MA, Hayashi S, O’Shea AM, Burgart LJ, Smyrk TC, Shimizu D, Waring PM, Ruszkiewicz AR, Pollett AF, Redston M. Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study. Gastroenterology. 2007;133:48-56. [PMID: 17631130 DOI: 10.1053/j.gastro.2007.04.044] [Cited by in Crossref: 226] [Cited by in F6Publishing: 191] [Article Influence: 15.1] [Reference Citation Analysis]
100 Wang G, Kuppermann M, Kim B, Phillips KA, Ladabaum U. Influence of patient preferences on the cost-effectiveness of screening for lynch syndrome. J Oncol Pract 2012;8:e24s-30s. [PMID: 22942831 DOI: 10.1200/JOP.2011.000535] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
101 Pande M, Amos CI, Osterwisch DR, Chen J, Lynch PM, Broaddus R, Frazier ML. Genetic variation in genes for the xenobiotic-metabolizing enzymes CYP1A1, EPHX1, GSTM1, GSTT1, and GSTP1 and susceptibility to colorectal cancer in Lynch syndrome. Cancer Epidemiol Biomarkers Prev 2008;17:2393-401. [PMID: 18768509 DOI: 10.1158/1055-9965.EPI-08-0326] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
102 Lastella P, Patruno M, Forte G, Montanaro A, Di Gregorio C, Sabbà C, Suppressa P, Piepoli A, Panza A, Andriulli A. Identification and surveillance of 19 Lynch syndrome families in southern Italy: report of six novel germline mutations and a common founder mutation. Fam Cancer. 2011;10:285-295. [PMID: 21286823 DOI: 10.1007/s10689-011-9419-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
103 Byfield SA, Syngal S. Clinical guidelines versus universal molecular testing: are we ready to choose an optimal strategy for Lynch syndrome identification? Am J Gastroenterol. 2008;103:2837-2840. [PMID: 19032469 DOI: 10.1111/j.1572-0241.2008.02091.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
104 Boland CR. The mystery of mismatch repair deficiency: lynch or lynch-like? Gastroenterology 2013;144:868-70. [PMID: 23523847 DOI: 10.1053/j.gastro.2013.03.014] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
105 van Lier MG, Wagner A, van Leerdam ME, Biermann K, Kuipers EJ, Steyerberg EW, Dubbink HJ, Dinjens WN. A review on the molecular diagnostics of Lynch syndrome: a central role for the pathology laboratory. J Cell Mol Med 2010;14:181-97. [PMID: 19929944 DOI: 10.1111/j.1582-4934.2009.00977.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 3.9] [Reference Citation Analysis]
106 Lee SY, Kim DW, Shin YK, Ihn MH, Lee SM, Oh HK, Ku JL, Jeong SY, Lee JB, Ahn S, Won S, Kang SB. Validation of Prediction Models for Mismatch Repair Gene Mutations in Koreans. Cancer Res Treat 2016;48:668-75. [PMID: 26044159 DOI: 10.4143/crt.2014.288] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
107 Sinicrope FA, Yang ZJ. Prognostic and predictive impact of DNA mismatch repair in the management of colorectal cancer. Future Oncol 2011;7:467-74. [PMID: 21417908 DOI: 10.2217/fon.11.5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
108 Suzuki O, Eguchi H, Chika N, Sakimoto T, Ishibashi K, Kumamoto K, Tamaru JI, Tachikawa T, Akagi K, Arai T, Okazaki Y, Ishida H. Prevalence and clinicopathologic/molecular characteristics of mismatch repair-deficient colorectal cancer in the under-50-year-old Japanese population. Surg Today 2017;47:1135-46. [PMID: 28258479 DOI: 10.1007/s00595-017-1486-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
109 Monteiro Santos EM, Valentin MD, Carneiro F, de Oliveira LP, de Oliveira Ferreira F, Junior SA, Nakagawa WT, Gomy I, de Faria Ferraz VE, da Silva Junior WA, Carraro DM, Rossi BM. Predictive models for mutations in mismatch repair genes: implication for genetic counseling in developing countries. BMC Cancer 2012;12:64. [PMID: 22321913 DOI: 10.1186/1471-2407-12-64] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
110 Hampel H. Genetic testing for hereditary colorectal cancer. Surg Oncol Clin N Am 2009;18:687-703. [PMID: 19793575 DOI: 10.1016/j.soc.2009.08.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
111 Salman P, Panay S, Fernández R, Mahave M, Soza-Ried C. Evidence of response to pembrolizumab in a patient with Lynch syndrome-related metastatic colon cancer. Onco Targets Ther 2018;11:7295-300. [PMID: 30425520 DOI: 10.2147/OTT.S167645] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
112 Kastrinos F, Steyerberg EW. Family matters in lynch syndrome. J Natl Cancer Inst 2015;107:djv050. [PMID: 25794515 DOI: 10.1093/jnci/djv050] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
113 Smith JD, Lowery MA, Fell D, Gallagher DJ, Nash GM, Kemeny NE. Young patients with synchronous colorectal liver metastases. J Surg Oncol 2016;113:473-6. [PMID: 27110700 DOI: 10.1002/jso.24181] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
114 Crosbie EJ, Ryan NAJ, Arends MJ, Bosse T, Burn J, Cornes JM, Crawford R, Eccles D, Frayling IM, Ghaem-Maghami S, Hampel H, Kauff ND, Kitchener HC, Kitson SJ, Manchanda R, McMahon RFT, Monahan KJ, Menon U, Møller P, Möslein G, Rosenthal A, Sasieni P, Seif MW, Singh N, Skarrott P, Snowsill TM, Steele R, Tischkowitz M, Evans DG; Manchester International Consensus Group. The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome. Genet Med 2019;21:2390-400. [PMID: 30918358 DOI: 10.1038/s41436-019-0489-y] [Cited by in Crossref: 64] [Cited by in F6Publishing: 58] [Article Influence: 21.3] [Reference Citation Analysis]
115 Dowty JG, Win AK, Buchanan DD, Lindor NM, Macrae FA, Clendenning M, Antill YC, Thibodeau SN, Casey G, Gallinger S, Marchand LL, Newcomb PA, Haile RW, Young GP, James PA, Giles GG, Gunawardena SR, Leggett BA, Gattas M, Boussioutas A, Ahnen DJ, Baron JA, Parry S, Goldblatt J, Young JP, Hopper JL, Jenkins MA. Cancer risks for MLH1 and MSH2 mutation carriers. Hum Mutat 2013;34:490-7. [PMID: 23255516 DOI: 10.1002/humu.22262] [Cited by in Crossref: 155] [Cited by in F6Publishing: 139] [Article Influence: 17.2] [Reference Citation Analysis]
116 Tomita N, Ishida H, Tanakaya K, Yamaguchi T, Kumamoto K, Tanaka T, Hinoi T, Miyakura Y, Hasegawa H, Takayama T, Ishikawa H, Nakajima T, Chino A, Shimodaira H, Hirasawa A, Nakayama Y, Sekine S, Tamura K, Akagi K, Kawasaki Y, Kobayashi H, Arai M, Itabashi M, Hashiguchi Y, Sugihara K; Japanese Society for Cancer of the Colon, Rectum. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2020 for the Clinical Practice of Hereditary Colorectal Cancer. Int J Clin Oncol 2021;26:1353-419. [PMID: 34185173 DOI: 10.1007/s10147-021-01881-4] [Reference Citation Analysis]
117 Wang Y, Li D, Li X, Teng C, Zhu L, Cui B, Zhao Y, Hu F. Prognostic significance of hMLH1/hMSH2 gene mutations and hMLH1 promoter methylation in sporadic colorectal cancer. Med Oncol. 2014;31:39. [PMID: 24990217 DOI: 10.1007/s12032-014-0039-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
118 Kheirelseid EA, Miller N, Chang KH, Curran C, Hennessey E, Sheehan M, Kerin MJ. Mismatch repair protein expression in colorectal cancer. J Gastrointest Oncol. 2013;4:397-408. [PMID: 24294512 DOI: 10.3978/j.issn.2078-6891.2013.021] [Cited by in F6Publishing: 23] [Reference Citation Analysis]
119 Thompson BA, Spurdle AB, Plazzer JP, Greenblatt MS, Akagi K, Al-Mulla F, Bapat B, Bernstein I, Capellá G, den Dunnen JT. Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database. Nat Genet. 2014;46:107-115. [PMID: 24362816 DOI: 10.1038/ng.2854] [Cited by in Crossref: 323] [Cited by in F6Publishing: 279] [Article Influence: 35.9] [Reference Citation Analysis]
120 Chu M, Zhang R, Zhao Y, Wu C, Guo H, Zhou B, Lu J, Shi Y, Dai J, Jin G. A genome-wide gene-gene interaction analysis identifies an epistatic gene pair for lung cancer susceptibility in Han Chinese. Carcinogenesis. 2014;35:572-577. [PMID: 24325914 DOI: 10.1093/carcin/bgt400] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
121 Ito S, Shiraishi M, Tsuchihashi K, Takatsuka R, Yamamoto J, Kuraoka I, Iwai S. Fluorescence detection of DNA mismatch repair in human cells. Sci Rep 2018;8:12181. [PMID: 30111891 DOI: 10.1038/s41598-018-30733-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
122 Dunlop MG, Tenesa A, Farrington SM, Ballereau S, Brewster DH, Koessler T, Pharoah P, Schafmayer C, Hampe J, Völzke H. Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42,103 individuals. Gut. 2013;62:871-881. [PMID: 22490517 DOI: 10.1136/gutjnl-2011-300537] [Cited by in Crossref: 85] [Cited by in F6Publishing: 90] [Article Influence: 8.5] [Reference Citation Analysis]
123 Kastrinos F, Balmaña J, Syngal S. Prediction models in Lynch syndrome. Fam Cancer 2013;12:217-28. [PMID: 23553450 DOI: 10.1007/s10689-013-9632-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
124 Serrano M, Lage P, Belga S, Filipe B, Francisco I, Rodrigues P, Fonseca R, Chaves P, Claro I, Albuquerque C, Pereira AD. Bethesda criteria for microsatellite instability testing: impact on the detection of new cases of Lynch syndrome. Fam Cancer 2012;11:571-8. [PMID: 22776989 DOI: 10.1007/s10689-012-9550-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
125 Goshayeshi L, Ghaffarzadegan K, Khooei A, Esmaeilzadeh A, Rahmani Khorram M, Mosannen Mozaffari H, Kiani B, Hoseini B. Prevalence and clinicopathological characteristics of mismatch repair-deficient colorectal carcinoma in early onset cases as compared with late-onset cases: a retrospective cross-sectional study in Northeastern Iran. BMJ Open 2018;8:e023102. [PMID: 30166308 DOI: 10.1136/bmjopen-2018-023102] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
126 Ling C, Yang W, Sun H, Ge M, Ji Y, Han S, Zhang D, Zhang X. Rare compound heterozygous mutations in gene MSH6 cause constitutive mismatch repair deficiency syndrome. Clin Case Rep 2018;6:1448-51. [PMID: 30147880 DOI: 10.1002/ccr3.1564] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
127 Hewish M, Lord CJ, Martin SA, Cunningham D, Ashworth A. Mismatch repair deficient colorectal cancer in the era of personalized treatment. Nat Rev Clin Oncol 2010;7:197-208. [DOI: 10.1038/nrclinonc.2010.18] [Cited by in Crossref: 142] [Cited by in F6Publishing: 131] [Article Influence: 11.8] [Reference Citation Analysis]
128 Kets CM, van Krieken JH, Hebeda KM, Wezenberg SJ, Goossens M, Brunner HG, Ligtenberg MJ, Hoogerbrugge N. Very low prevalence of germline MSH6 mutations in hereditary non-polyposis colorectal cancer suspected patients with colorectal cancer without microsatellite instability. Br J Cancer 2006;95:1678-82. [PMID: 17117178 DOI: 10.1038/sj.bjc.6603478] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
129 Zhang Y, Chen H, Peng Z, Banerjee S, Li W, Zhao Z, Sun J, Lv J, Huang H, Bai R, Lin K, Li Z. A Novel MLH1 Initiation Codon Mutation (c.3G>T) in a Large Chinese Lynch Syndrome Family with Different Onset Age and mRNA Expression Level. Biomed Res Int 2018;2018:1460835. [PMID: 30539002 DOI: 10.1155/2018/1460835] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
130 Lastra E, García-González M, Llorente B, Bernuy C, Barrio MJ, Pérez-Cabornero L, Durán M, García-Girón C. Lynch syndrome diagnostics: decision-making process for germ-line testing. Clin Transl Oncol 2012;14:254-62. [PMID: 22484632 DOI: 10.1007/s12094-012-0793-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
131 Stinton C, Jordan M, Fraser H, Auguste P, Court R, Al-Khudairy L, Madan J, Grammatopoulos D, Taylor-Phillips S. Testing strategies for Lynch syndrome in people with endometrial cancer: systematic reviews and economic evaluation. Health Technol Assess 2021;25:1-216. [PMID: 34169821 DOI: 10.3310/hta25420] [Reference Citation Analysis]
132 Barzi A, Sadeghi S, Kattan MW, Meropol NJ. Comparative effectiveness of screening strategies for Lynch syndrome. J Natl Cancer Inst 2015;107:djv005. [PMID: 25794514 DOI: 10.1093/jnci/djv005] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 4.6] [Reference Citation Analysis]
133 Briffa R, Um I, Faratian D, Zhou Y, Turnbull AK, Langdon SP, Harrison DJ. Multi-Scale Genomic, Transcriptomic and Proteomic Analysis of Colorectal Cancer Cell Lines to Identify Novel Biomarkers. PLoS One 2015;10:e0144708. [PMID: 26678268 DOI: 10.1371/journal.pone.0144708] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
134 Kastrinos F, Syngal S. Inherited colorectal cancer syndromes. Cancer J. 2011;17:405-415. [PMID: 22157284 DOI: 10.1097/ppo.0b013e318237e408] [Cited by in Crossref: 71] [Cited by in F6Publishing: 32] [Article Influence: 7.1] [Reference Citation Analysis]
135 Moreira L, Balaguer F, Lindor N, de la Chapelle A, Hampel H, Aaltonen LA, Hopper JL, Le Marchand L, Gallinger S, Newcomb PA, Haile R, Thibodeau SN, Gunawardena S, Jenkins MA, Buchanan DD, Potter JD, Baron JA, Ahnen DJ, Moreno V, Andreu M, Ponz de Leon M, Rustgi AK, Castells A; EPICOLON Consortium. Identification of Lynch syndrome among patients with colorectal cancer. JAMA 2012;308:1555-65. [PMID: 23073952 DOI: 10.1001/jama.2012.13088] [Cited by in Crossref: 302] [Cited by in F6Publishing: 255] [Article Influence: 30.2] [Reference Citation Analysis]
136 Ljubic B, Pavlovski M, Alshehri J, Roychoudhury S, Bajic V, Van Neste C, Obradovic Z. Comorbidity network analysis and genetics of colorectal cancer. Informatics in Medicine Unlocked 2020;21:100492. [DOI: 10.1016/j.imu.2020.100492] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
137 Kets CM, Hoogerbrugge N, van Krieken JH, Goossens M, Brunner HG, Ligtenberg MJ. Compound heterozygosity for two MSH2 mutations suggests mild consequences of the initiation codon variant c.1A>G of MSH2. Eur J Hum Genet 2009;17:159-64. [PMID: 18781192 DOI: 10.1038/ejhg.2008.153] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
138 Balaguer F, Balmaña J, Castellví-Bel S, Steyerberg EW, Andreu M, Llor X, Jover R, Syngal S, Castells A; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Validation and extension of the PREMM1,2 model in a population-based cohort of colorectal cancer patients. Gastroenterology 2008;134:39-46. [PMID: 18061181 DOI: 10.1053/j.gastro.2007.10.042] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 2.5] [Reference Citation Analysis]
139 Stoffel EM, Mercado RC, Kohlmann W, Ford B, Grover S, Conrad P, Blanco A, Shannon KM, Powell M, Chung DC, Terdiman J, Gruber SB, Syngal S. Prevalence and predictors of appropriate colorectal cancer surveillance in Lynch syndrome. Am J Gastroenterol 2010;105:1851-60. [PMID: 20354509 DOI: 10.1038/ajg.2010.120] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 4.1] [Reference Citation Analysis]
140 Maratt JK, Stoffel E. Identification of Lynch Syndrome. Gastrointest Endosc Clin N Am 2022;32:45-58. [PMID: 34798986 DOI: 10.1016/j.giec.2021.09.002] [Reference Citation Analysis]
141 Marie Lewis K. Identifying hereditary cancer: Genetic counseling and cancer risk assessment. Current Problems in Cancer 2014;38:216-25. [DOI: 10.1016/j.currproblcancer.2014.10.002] [Cited by in Crossref: 6] [Article Influence: 0.8] [Reference Citation Analysis]
142 Ryan NA, McMahon RF, Ramchander NC, Seif MW, Evans DG, Crosbie EJ. Lynch syndrome for the gynaecologist. Obstet Gynaecol 2021;23:9-20. [PMID: 33679238 DOI: 10.1111/tog.12706] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
143 Jenkins MA, Southey MC, Giles GG, Hopper JL. Rationale for, and approach to, studying modifiers of risk in persons with a genetic predisposition to colorectal cancer. Curr Oncol Rep 2007;9:202-7. [PMID: 17430691 DOI: 10.1007/s11912-007-0022-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
144 Li Z, Fang ZY, Ding Y, Yao WT, Yang Y, Zhu ZQ, Wang W, Zhang QX. Amplifications of NCOA3 gene in colorectal cancers in a Chinese population. World J Gastroenterol 2012; 18(8): 855-860 [PMID: 22371647 DOI: 10.3748/wjg.v18.i8.855] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
145 Bruegl AS, Djordjevic B, Batte B, Daniels M, Fellman B, Urbauer D, Luthra R, Sun C, Lu KH, Broaddus RR. Evaluation of clinical criteria for the identification of Lynch syndrome among unselected patients with endometrial cancer. Cancer Prev Res (Phila) 2014;7:686-97. [PMID: 24771847 DOI: 10.1158/1940-6207.CAPR-13-0359] [Cited by in Crossref: 34] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
146 Landsbergen KM, Prins JB, Brunner HG, van Duijvendijk P, Nagengast FM, van Krieken JH, Ligtenberg M, Hoogerbrugge N. Psychological distress in newly diagnosed colorectal cancer patients following microsatellite instability testing for Lynch syndrome on the pathologist's initiative. Fam Cancer. 2012;11:259-267. [PMID: 22311584 DOI: 10.1007/s10689-012-9510-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
147 Naruse H, Ikawa N, Yamaguchi K, Nakamura Y, Arai M, Ishioka C, Sugano K, Tamura K, Tomita N, Matsubara N, Yoshida T, Moriya Y, Furukawa Y. Determination of splice-site mutations in Lynch syndrome (hereditary non-polyposis colorectal cancer) patients using functional splicing assay. Fam Cancer 2009;8:509-17. [PMID: 19685281 DOI: 10.1007/s10689-009-9280-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
148 Cruz-Correa M, Pérez-Mayoral J, Dutil J, Echenique M, Mosquera R, Rivera-Román K, Umpierre S, Rodriguez-Quilichini S, Gonzalez-Pons M, Olivera MI, Pardo S; Puerto Rico Clinical Cancer Genetics Consortia. Hereditary cancer syndromes in Latino populations: genetic characterization and surveillance guidelines. Hered Cancer Clin Pract 2017;15:3. [PMID: 28127413 DOI: 10.1186/s13053-017-0063-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]